Please check your internet connection and try again.
# Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide
## Overview
Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide is a sedative and hypnotic medication belonging to the class of non-benzodiazepine hypnotics. It acts as an agonist at the GABA-A receptor complex.
## Primary Indications
Short-term management of insomnia characterized by difficulty falling asleep.
## Adult Dosing
* **Initial Dose:** 10 mg taken immediately before bedtime.
* **Maximum Dose:** 10 mg once daily.
* **For Elderly or Debilitated Patients:** Consider 5 mg taken immediately before bedtime.
## Pediatric Dosing
Data is insufficient to recommend use in pediatric patients.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. A dose reduction may be considered, though specific recommendations vary.
* **Renal Impairment:** No specific dose adjustment is typically required, but use with caution.
## Contraindications
* Known hypersensitivity to the drug.
* Severe hepatic impairment.
* Sleep apnea syndrome.
* Severe respiratory insufficiency.
* History of complex sleep behaviors (e.g., sleepwalking, sleep-driving) after taking the medication.
## Adverse Effects
Common: Drowsiness, dizziness, headache, nausea, fatigue.
Less Common: Hallucinations, agitation, anterograde amnesia, dependence, tolerance, withdrawal symptoms, complex sleep behaviors.
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, benzodiazepines, opioids, antipsychotics, antihistamines):** Additive CNS depression. Avoid concurrent use or use with extreme caution.
* **CYP3A4 Inhibitors (e.g., ketoconazole, itraconazole):** May increase plasma concentrations of Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide.
* **CYP3A4 Inducers (e.g., rifampin, carbamazepine, phenytoin):** May decrease plasma concentrations of Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide.
## Monitoring
* Effectiveness for insomnia.
* Signs of dependence or withdrawal.
* Potential for complex sleep behaviors.
* Daytime impairment.
## Clinical Pearls
* Administer immediately before bedtime.
* Should be used for the shortest duration necessary.
* Patients should avoid alcohol while taking this medication due to increased risk of severe sedation.
* Complex sleep behaviors can occur even with the first dose. Advise patients and their families to stop the drug and seek medical attention immediately if such behaviors occur.
* Tolerance to the sedative effects may develop within a few weeks.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the official prescribing information and current clinical guidelines for the most up-to-date and complete drug information. This response does not substitute for professional medical judgment.